AI Integration with BestRx Prescription Review

The integration surfaces AI within the core prescription review workflow, primarily at two key points: the New Prescription Entry screen and the Verification Queue. For new scripts—whether from scanned paper, e-prescriptions (via Surescripts), or manual entry—an AI agent acts as a pre-verification layer. It extracts and validates key data fields (e.g., drug name, strength, SIG, patient age) against the NDC database and the patient's profile in BestRx, flagging potential mismatches or missing elements before the pharmacist begins their review. This reduces the 'clean-up' time spent correcting OCR errors or incomplete transmissions.

During active pharmacist review, the AI provides real-time, context-aware clinical support. By calling the patient's medication history, allergies, and diagnosis codes from the BestRx database, the agent runs advanced checks beyond basic DUR. It surfaces relevant alerts for drug-drug interactions, therapeutic duplication, dosage appropriateness based on age/renal function, and potential prior authorization triggers based on the drug and the patient's insurance plan on file. These insights are injected as structured annotations directly into the BestRx UI, allowing the pharmacist to quickly assess and act, turning a manual research task into a guided decision.

Governance is built into the workflow. All AI-generated flags and recommendations are logged in the prescription's audit trail with a clear AI-Suggested tag, maintaining a transparent record for compliance. The system is designed for a pharmacist-in-the-loop model; no AI action auto-approves a prescription. Final verification and override authority always remain with the licensed pharmacist. Rollout typically starts in a monitoring-only mode, where AI suggestions are visible but not disruptive, allowing the pharmacy team to build trust in the alerts before fully integrating them into their standard operating procedure.

The integration is event-driven, triggered at two key points in the BestRx workflow: 1) upon e-prescription receipt or scanned script upload, and 2) during the pharmacist's verification queue review. For e-prescriptions, the AI agent is invoked via a webhook from BestRx's incoming Rx feed. For scanned paper scripts, the integration taps into the platform's Optical Character Recognition (OCR) output layer. The agent's first task is data extraction and validation, comparing the extracted sig, drug, and patient details against the structured data in the BestRx patient profile and drug database to flag mismatches or missing elements like SIG code or refills.

Once the prescription data is structured, a second AI process performs the clinical safety review. This agent calls a Retrieval-Augmented Generation (RAG) system grounded in the pharmacy's specific patient medication history (pulled via BestRx API), allergy lists, and an up-to-date drug interaction database. The AI evaluates for drug-drug interactions, therapeutic duplication, and dosage appropriateness based on age and diagnosis codes. Findings are formatted as structured alerts (e.g., SEVERITY: HIGH, INTERACTION: Warfarin and Sulfamethoxazole/Trimethoprim) and appended to a dedicated AI_Review_Notes custom field on the prescription record, visible within the verification screen.

For rollout, the system is designed for a pharmacist-in-the-loop model. AI-generated notes and alerts are presented as non-binding recommendations within the existing BestRx UI, requiring pharmacist review and final approval. All AI interactions are logged in a separate audit trail, recording the input data, model reasoning, and output to support compliance. Governance is managed through a configuration dashboard where pharmacy managers can adjust alert sensitivity, toggle specific review modules (e.g., turn off dosage checks for oncology drugs), and set up escalation rules for high-severity alerts to require a second pharmacist review.

Integrating AI into BestRx's prescription review requires a phased, event-driven architecture that respects the existing workflow. The typical pattern involves: 1) Data Extraction Layer: An AI service listens for new scanned scripts or e-prescriptions via BestRx's API or database hooks, extracting patient, drug, and prescriber data into a structured JSON payload. 2) Clinical Review Agent: This payload is routed to a governed LLM, which performs safety checks (drug-drug interactions, dosage appropriateness, allergy conflicts) against the patient's profile and external knowledge bases. 3) Pharmacist-in-the-Loop Interface: Findings are injected back into the BestRx verification queue as a structured alert or recommendation note, attached to the specific prescription record, requiring final pharmacist approval before dispensing.

Security is paramount. All data in transit and at rest is encrypted, and the AI service operates under the same role-based access controls (RBAC) as BestRx, ensuring only authorized staff can view AI-generated notes. Audit trails log every AI interaction—the input data, the model's reasoning, and the final recommendation—directly within the platform's activity log for full traceability. This creates a defensible, transparent record for regulatory reviews and internal quality assurance.

Rollout follows a conservative, risk-managed approach. Start with a pilot on non-controlled substance prescriptions, using AI as a silent copilot where its suggestions are logged but not displayed. After validating accuracy and pharmacist feedback, enable targeted alerts for high-risk interactions only, gradually expanding to broader safety checks. The final phase integrates AI suggestions directly into the verification screen, reducing data entry clicks and allowing pharmacists to accept recommendations with a single click. This phased method builds trust, measures impact on error reduction and review time, and ensures the AI augments—never replaces—clinical judgment.